Mine sisu juurde

5-hydroxytryptamine receptor 1A

Lehekülje sisu ei toetata teistes keeltes.
Loo artikkel

See on automaatne vaade, mis põhineb projekti Vikiandmed andmetel.
Artiklit veel pole, kuid saad aidata seda luua.

mammalian protein found in Homo sapiens

Välised allikad

Freebase
/m/03cx8d7
Microsoft Academic ID
2781093953
2910224462
RefSeq protein ID
NP_000515[1]
Transporter Classification Database ID
9.A.14.3.14[2][3]
Guide to Pharmacology Target ID
1[4]
OpenAlex ID
C2781093953[5]
Ensembl protein ID
ENSP00000316244[6]
ENSP00000423433[7]
UniProt protein ID
P08908[8]

üksikjuht nähtusest

valk[8]

osa objektist

5-Hydroxytryptamine 1A receptor[9]
GPCR, rhodopsin-like, 7TM, protein family[10]

found in taxon

Homo sapiens[8]

encoded by

HTR1A[8]

molecular function

G protein-coupled receptor activity[11][12]

määramismeetod: IEA

signal transducer activity[13]

määramismeetod: IEA

G protein-coupled serotonin receptor activity[14][15][12][16][17]

määramismeetod: IDA, IEA, IMP, TAS

ravimi seotus vereplasma valkudega[18][19]

määramismeetod: IPI

serotonin binding[20]

määramismeetod: IBA

neurotransmitter receptor activity[20]

määramismeetod: IBA

receptor-receptor interaction[21]

määramismeetod: IDA

G protein-coupled receptor activity[22][23][20]

määramismeetod: IBA, IEA

G protein-coupled serotonin receptor activity[24][25][23][26][27][20]

määramismeetod: IBA, IDA, IEA, IMP, TAS

cell component

integral component of membrane[22][23]

määramismeetod: IEA

membrane[22]

määramismeetod: IEA

Rakumembraan[28][22]

määramismeetod: TAS, IEA

integral component of plasma membrane[29][12][30]

määramismeetod: IDA, IEA, TAS

integral component of plasma membrane[31][23][32][20]

määramismeetod: IBA, IDA, IEA, TAS

Dendriit[20]

määramismeetod: IBA

biological process

G protein-coupled receptor signaling pathway[28][33][25][22][23]

määramismeetod: IEA, IMP, TAS

regulation of behavior[23]

määramismeetod: IEA

vasoconstriction[23]

määramismeetod: IEA

adenylate cyclase-inhibiting serotonin receptor signaling pathway[17]

määramismeetod: IDA

serotonin metabolic process[34][26]

määramismeetod: ISS, IEA

behavioral fear response[34][26]

määramismeetod: ISS, IEA

regulation of dopamine metabolic process[34][26]

määramismeetod: ISS, IEA

regulation of serotonin secretion[34][26]

määramismeetod: ISS, IEA

exploration behavior[34][26]

määramismeetod: ISS, IEA

serotonin receptor signaling pathway[34][26]

määramismeetod: ISS, IEA

positive regulation of cell population proliferation[33]

määramismeetod: TAS

regulation of hormone secretion[23]

määramismeetod: IEA

proliferatsioon[23]

määramismeetod: IEA

Signaaliülekanne[22]

määramismeetod: IEA

animal behaviour[22]

määramismeetod: IEA

G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger[20]

määramismeetod: IBA

adenylate cyclase-inhibiting serotonin receptor signaling pathway[27][20]

määramismeetod: IBA, IDA

chemical synaptic transmission[20]

määramismeetod: IBA

physically interacts with

flibanserin[35]

kasutus: Agonist

frovatriptan[36]

kasutus: Agonist

LP-12[37]

kasutus: Agonist

LP-211[38]

kasutus: Agonist

LP-44[39]

kasutus: Agonist

1-naphthylpiperazine[40]

kasutus: Agonist

5-carboxamidotryptamine[41]

kasutus: Agonist

Serotoniin[42]

kasutus: Agonist

(+/-)-8-hydroxy-2-(di-N-propylamino)tetralin[43][44]

kasutus: Agonist

aripiprazole[45]

kasutus: Agonist

bmy-14802[46]

kasutus: Agonist

cabergoline[47]

kasutus: Agonist

clozapine[48]

kasutus: Agonist

CP 93129[49]

kasutus: Agonist

donitriptan[50]

kasutus: Agonist

eletriptan[51]

kasutus: Agonist

EMDT[52]

kasutus: Agonist

flesinoxan[53]

kasutus: Agonist

lisuride[54]

kasutus: Agonist

LSD[55]

kasutus: Agonist

LY293284[56]

kasutus: Agonist

LY334370[57]

kasutus: Agonist

nafadotride[58]

kasutus: Agonist

naratriptan[59]

kasutus: Agonist

f-15599[60]

kasutus: Agonist

ocaperidone[61]

kasutus: Agonist

Olansapiin[62]

kasutus: Agonist

quetiapine[63]

kasutus: Agonist

quinpirole[64]

kasutus: Agonist

rizatriptan[65]

kasutus: Agonist

ru-24969[66]

kasutus: Agonist

S-14506[67]

kasutus: Agonist

S-14671[68]

kasutus: Agonist

spiroxatrine[69]

kasutus: Agonist

sumatriptan[70]

kasutus: Agonist

tandospirone[71]

kasutus: Agonist

U92016A[72]

kasutus: Agonist

xanomeline[73]

kasutus: Agonist

zalospirone[74]

kasutus: Agonist

zolmitriptan[75]

kasutus: Agonist

apomorphine[76]

kasutus: Agonist

BMY-7378[77]

kasutus: Agonist

brl-15572[78]

kasutus: Agonist

bromocriptine[79]

kasutus: Agonist

buspirone[80]

kasutus: Agonist

fluparoxan[81]

kasutus: Agonist

gr-127935[82]

kasutus: Agonist

ipsapirone[83]

kasutus: Agonist

pergolide[84]

kasutus: Agonist

piribedil[85]

kasutus: Agonist

roxindole[86]

kasutus: Agonist

S-15535[87][88]

kasutus: Agonist

sb-216641[89]

kasutus: Agonist

terguride[90]

kasutus: Agonist

vilazodone[91]

kasutus: Agonist

vortioxetine[92]

kasutus: Agonist

ziprasidone[93]

kasutus: Agonist

(+)-butaclamol[94]

kasutus: Antagonist

chlorpromazine[95]

kasutus: Antagonist

cyamemazine[96]

kasutus: Antagonist

fluspirilene[97]

kasutus: Antagonist

Haloperidool[98]

kasutus: Antagonist

iloperidone[99]

kasutus: Antagonist

apiose[100]

kasutus: Antagonist

ketanserin[101]

kasutus: Antagonist

mesoridazine[102]

kasutus: Antagonist

metitepine[103]

kasutus: Antagonist

NAN 190[104]

kasutus: Antagonist

pimozide[105]

kasutus: Antagonist

pindolol[106]

kasutus: Antagonist

pipamperone[107]

kasutus: Antagonist

pizotyline[108]

kasutus: Antagonist

raclopride[109]

kasutus: Antagonist

repinotan[110]

kasutus: Antagonist

risperidone[111]

kasutus: Antagonist

ritanserin[112]

kasutus: Antagonist

robalzotan[113]

kasutus: Antagonist

sertindole[114]

kasutus: Antagonist

spiperone[115]

kasutus: Antagonist

thioridazine[116]

kasutus: Antagonist

tiospirone[117]

kasutus: Antagonist

WAY-100135[118]

kasutus: Antagonist

WAY-100635[119]

kasutus: Antagonist

yohimbine[120]

kasutus: Antagonist

zotepine[121]

kasutus: Antagonist

xaliproden[122]

objektil on roll: Agonist

zimeldine[123]

objektil on roll: Antagonist

aripiprazole lauroxil[124]

objektil on roll: Partial agonist

gepirone[125]

objektil on roll: Agonist

buspirone hydrochloride[126]

objektil on roll: Partial agonist

koosseisu osa

GPCR, rhodopsin-like, 7TM[9]

Commonsi kategooria

5-HT1A serotonin receptor

teema peakategooria

Category:5-HT1A serotonin receptor

Viited

  1. ↑ NCBI Gene, 30. mai 2020, 3350
  2. ↑ Transporter Classification database, 13. märts 2020
  3. ↑ Transporter Classification database, 29. aprill 2020
  4. ↑ https://www.wikidata.org/w/index.php?title=Wikidata:Property_proposal/Guide_to_Pharmacology_Target_ID&oldid=709819452
  5. ↑ OpenAlex, 26. jaanuar 2022, https://docs.openalex.org/download-snapshot/snapshot-data-format
  6. ↑ Ensembl Release 99, ENSP00000316244
  7. ↑ Ensembl Release 99, ENSP00000423433
  8. ↑ 8,0 8,1 8,2 8,3 UniProt, 13. november 2019, P08908
  9. ↑ 9,0 9,1 InterPro Release 71.0, http://www.ebi.ac.uk/interpro/protein/P08908
  10. ↑ inferred from protein domain or family
  11. ↑ IEA, 16. juuli 2018, P08908, GOA, http://www.ebi.ac.uk/QuickGO/annotations?protein=P08908&geneProductId=UniProtKB:P08908, UniProt
  12. ↑ 12,0 12,1 12,2 IEA, http://www.ebi.ac.uk/QuickGO/annotations?protein=P08908&geneProductId=UniProtKB:P08908, 16. juuli 2018, InterPro, GOA
  13. ↑ IEA, 1. jaanuar 2018, P08908, GOA, http://www.ebi.ac.uk/QuickGO/annotations?protein=P08908&geneProductId=UniProtKB:P08908, UniProt
  14. ↑ TAS, http://www.ebi.ac.uk/QuickGO/annotations?protein=P08908&geneProductId=UniProtKB:P08908, 16. juuli 2018, Proteome Inc., Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity, GOA
  15. ↑ IMP, 16. juuli 2018, P08908, Role of glycosphingolipids in the function of human serotonin₁A receptors, GOA, http://www.ebi.ac.uk/QuickGO/annotations?protein=P08908&geneProductId=UniProtKB:P08908, UniProt
  16. ↑ IEA, http://www.ebi.ac.uk/QuickGO/annotations?protein=P08908&geneProductId=UniProtKB:P08908, 16. juuli 2018, Ensembl genome database project, GOA
  17. ↑ 17,0 17,1 IDA, 16. juuli 2018, P08908, Expression of 5HT1a receptors on activated human T cells. Regulation of cyclic AMP levels and T cell proliferation by 5-hydroxytryptamine, GOA, http://www.ebi.ac.uk/QuickGO/annotations?protein=P08908&geneProductId=UniProtKB:P08908, UniProt
  18. ↑ IPI, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, 8. aprill 2019, Parkinsons Disease Gene Ontology Initiative, Dynamic modulation of FGFR1-5-HT1A heteroreceptor complexes. Agonist treatment enhances participation of FGFR1 and 5-HT1A homodimers and recruitment of β-arrestin2, GOA
  19. ↑ IPI, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, 8. aprill 2019, IntAct protein interaction database, Fibroblast growth factor receptor 1- 5-hydroxytryptamine 1A heteroreceptor complexes and their enhancement of hippocampal plasticity, GOA
  20. ↑ 20,0 20,1 20,2 20,3 20,4 20,5 20,6 20,7 20,8 IBA, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, 8. aprill 2019, GO Central, Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium, GOA
  21. ↑ IDA, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, 8. aprill 2019, Parkinsons Disease Gene Ontology Initiative, Dynamic modulation of FGFR1-5-HT1A heteroreceptor complexes. Agonist treatment enhances participation of FGFR1 and 5-HT1A homodimers and recruitment of β-arrestin2, GOA
  22. ↑ 22,0 22,1 22,2 22,3 22,4 22,5 22,6 IEA, 8. aprill 2019, P08908, GOA, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, UniProt
  23. ↑ 23,0 23,1 23,2 23,3 23,4 23,5 23,6 23,7 23,8 IEA, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, 8. aprill 2019, InterPro, GOA
  24. ↑ TAS, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, 8. aprill 2019, Proteome Inc., Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity, GOA
  25. ↑ 25,0 25,1 IMP, 8. aprill 2019, P08908, Role of glycosphingolipids in the function of human serotonin₁A receptors, GOA, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, UniProt
  26. ↑ 26,0 26,1 26,2 26,3 26,4 26,5 26,6 IEA, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, 8. aprill 2019, Ensembl genome database project, GOA
  27. ↑ 27,0 27,1 IDA, 8. aprill 2019, P08908, Expression of 5HT1a receptors on activated human T cells. Regulation of cyclic AMP levels and T cell proliferation by 5-hydroxytryptamine, GOA, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, UniProt
  28. ↑ 28,0 28,1 TAS, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, 8. aprill 2019, Reactome, GOA
  29. ↑ TAS, http://www.ebi.ac.uk/QuickGO/annotations?protein=P08908&geneProductId=UniProtKB:P08908, 16. juuli 2018, Proteome Inc., The genomic clone G-21 which resembles a beta-adrenergic receptor sequence encodes the 5-HT1A receptor, GOA
  30. ↑ IDA, 16. juuli 2018, P08908, Role of glycosphingolipids in the function of human serotonin₁A receptors, GOA, http://www.ebi.ac.uk/QuickGO/annotations?protein=P08908&geneProductId=UniProtKB:P08908, UniProt
  31. ↑ TAS, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, 8. aprill 2019, Proteome Inc., The genomic clone G-21 which resembles a beta-adrenergic receptor sequence encodes the 5-HT1A receptor, GOA
  32. ↑ IDA, 8. aprill 2019, P08908, Role of glycosphingolipids in the function of human serotonin₁A receptors, GOA, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, UniProt
  33. ↑ 33,0 33,1 TAS, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, 8. aprill 2019, Proteome Inc., Activation of 5-HT1A receptors expressed in NIH-3T3 cells induces focus formation and potentiates EGF effect on DNA synthesis, GOA
  34. ↑ 34,0 34,1 34,2 34,3 34,4 34,5 ISS, 8. aprill 2019, P08908, GOA, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, UniProt
  35. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 8182, inglise keel
  36. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 7191, inglise keel
  37. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 8434, inglise keel
  38. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 8436, inglise keel
  39. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 8435, inglise keel
  40. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 3, inglise keel
  41. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 4, inglise keel
  42. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 5, inglise keel
  43. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 7, inglise keel
  44. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 31, inglise keel
  45. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 34, inglise keel
  46. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 8, inglise keel
  47. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 37, inglise keel
  48. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 38, inglise keel
  49. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 11, inglise keel
  50. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 39, inglise keel
  51. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 40, inglise keel
  52. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 12, inglise keel
  53. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 1, inglise keel
  54. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 43, inglise keel
  55. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 17, inglise keel
  56. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 19, inglise keel
  57. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 20, inglise keel
  58. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 44, inglise keel
  59. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 45, inglise keel
  60. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 3924, inglise keel
  61. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 46, inglise keel
  62. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 47, inglise keel
  63. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 50, inglise keel
  64. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 2, inglise keel
  65. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 51, inglise keel
  66. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 23, inglise keel
  67. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 24, inglise keel
  68. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 25, inglise keel
  69. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 53, inglise keel
  70. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 54, inglise keel
  71. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 55, inglise keel
  72. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 30, inglise keel
  73. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 57, inglise keel
  74. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 58, inglise keel
  75. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 60, inglise keel
  76. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 33, inglise keel
  77. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 9, inglise keel
  78. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 10, inglise keel
  79. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 35, inglise keel
  80. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 36, inglise keel
  81. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 41, inglise keel
  82. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 14, inglise keel
  83. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 42, inglise keel
  84. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 48, inglise keel
  85. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 49, inglise keel
  86. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 52, inglise keel
  87. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 26, inglise keel
  88. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 32, inglise keel
  89. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 28, inglise keel
  90. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 56, inglise keel
  91. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 7427, inglise keel
  92. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 7351, inglise keel
  93. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 59, inglise keel
  94. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 62, inglise keel
  95. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 83, inglise keel
  96. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 84, inglise keel
  97. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 85, inglise keel
  98. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 86, inglise keel
  99. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 87, inglise keel
  100. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 68, inglise keel
  101. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 88, inglise keel
  102. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 7227, inglise keel
  103. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 89, inglise keel
  104. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 73, inglise keel
  105. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 90, inglise keel
  106. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 91, inglise keel
  107. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 92, inglise keel
  108. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 93, inglise keel
  109. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 94, inglise keel
  110. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 95, inglise keel
  111. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 96, inglise keel
  112. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 97, inglise keel
  113. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 72, inglise keel
  114. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 98, inglise keel
  115. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 99, inglise keel
  116. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 100, inglise keel
  117. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 101, inglise keel
  118. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 79, inglise keel
  119. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 80, inglise keel
  120. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 102, inglise keel
  121. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 103, inglise keel
  122. ↑ Open Targets Platform, 14. august 2023, https://platform.opentargets.org/drug/CHEMBL1512580
  123. ↑ Open Targets Platform, 14. august 2023, https://platform.opentargets.org/drug/CHEMBL37744
  124. ↑ Open Targets Platform, 14. august 2023, https://platform.opentargets.org/drug/CHEMBL2219425
  125. ↑ Open Targets Platform, 14. august 2023, https://platform.opentargets.org/drug/CHEMBL284092
  126. ↑ Open Targets Platform, 14. august 2023, https://platform.opentargets.org/drug/CHEMBL1200399
Pärit leheküljelt "https://et.wikipedia.org/wiki/Eri:AboutTopic/Q21115043"